ArticleFrontiers in microbiology2016
Characteristics of Quinolone Resistance in
Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 82 citations in OpenAlex.
- Antibiotic resistance ofOpen veterinary journal · 2026Article
- Assessing Virulence Factor Genes in Pig-DerivedPathogens (Basel, Switzerland) · 2026Article
- Fluoroquinolone resistance without fluoroquinolone use; the genie is truly out of the bottle.Frontiers in microbiology · 2026Review
- Antimicrobial Resistance in SelectedAntibiotics (Basel, Switzerland) · 2025Review
- Characteristics of quinolone resistance in Escherichia coli isolated from wildlife in Poland.Scientific reports · 2025Article
- First national study on genomic profiling ofEnvironmental challenges (Amsterdam, Netherlands) · 2025Article
- Microbiome and Resistome in Poultry Litter-Fertilized and Unfertilized Agricultural Soils.Antibiotics (Basel, Switzerland) · 2025Article
- Genetic Determinants and Biofilm Properties Useful in Estimation of UTI Pathogenicity of theAntibiotics (Basel, Switzerland) · 2025Article
- Genomic Characterization and Antimicrobial Resistance of ESBL-Producing,Infection and drug resistance · 2025Article
- Prevalence and characterization of ESBL-producing diarrheagenicFrontiers in microbiology · 2025Article
- Comparative genomics of quinolone-resistant Escherichia coli from broilers and humans in Norway.BMC microbiology · 2024Article
- Plasmid-mediated quinolone resistance inIranian journal of microbiology · 2024Article
- One health transmission of fluoroquinolone-resistantOne health (Amsterdam, Netherlands) · 2023Article
- Antimicrobial Resistance Patterns and Risk Factors Associated with ESBL-Producing and MDRMicroorganisms · 2023Article
- Prevalence and mechanisms of ciprofloxacin resistance in Escherichia coli isolated from hospitalized patients, healthy carriers, and wastewaters in Iran.BMC microbiology · 2023Article
- Prevalence and Characterization of Extended-Spectrum β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2023Article
- Quinolone-resistant Escherichia coli at the interface between humans, poultry and their shared environment- a potential public health risk.One health outlook · 2023Article
- Article
- Irrigation Ponds as Sources of Antimicrobial-Resistant Bacteria in Agricultural Areas with Intensive Use of Poultry Litter.Antibiotics (Basel, Switzerland) · 2022Article
- Molecular characteristics of fluoroquinolone-resistant Escherichia coli isolated from suckling piglets with colibacillosis.BMC microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.